Syra Health Corp
corporate_fare Company Profile
Syra Health Corp (OTC:SYRA) is a publicly traded company in the Trade & Services sector. Wiseek has independently scored 15 items for SYRA at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-03, rated 8/10. Across its 15 most recent items scored 7 or higher, the top rating is 9/10, with 9 rated 8 or above. Recent SEC coverage for SYRA spans 10-Q, 8-K, DEFA14A, DEF 14A.
Recent high-impact activity:
- Syra Health Q3 10-Q: $835,831 Nine-Month Profit, Yet Going-Concern Warning Persists
- Syra Health Posts $2.56M in Q3 Revenue, Topping Last Quarter's $2.4M
- Syra Health Delivers a Second Straight Profitable Quarter but Warns Its Survival Is at Risk
- Syra Health Posts Second Straight Profitable Quarter, Revenue Up 23%
- Syra Health Seeks Shareholder Approval for 34% Equity Incentive Plan Increase
Financial Snapshot
Short Interest & Short Volume
24.20 days to coverFINRA reported short interest of 572,185 shares in SYRA as of the October 30, 2026 settlement, a 0.4% decrease from the prior period — about 24.2 days to cover at its recent average daily volume. On November 20, 2026, 29.8% of SYRA volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for SYRA, detected from its recent SEC filings.
Resale Registration for Series B Warrants · Warrant Terms
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →